DNA Microarray Market Size To Gain USD 5.04 Bn by 2032

The global DNA microarray market size was valued at USD 2.28 billion in 2023 and is projected to reach around USD 5.04 billion by 2032, representing a CAGR of 9.20% from 2023 to 2032.

The DNA microarray market is a dynamic sector characterized by the utilization of advanced genomic technologies. This market revolves around the analysis of multiple genes within a biological sample, enabling researchers and clinicians to understand gene expression patterns comprehensively. DNA microarrays play a pivotal role in genomics research, diagnostics, and personalized medicine, offering a high-throughput method for studying the expression of thousands of genes simultaneously.

Key Takeaways

• North America led the global market with the highest market share of 36% in 2022.
• Asia-Pacific is expected to expand at the fastest CAGR during the forecast period.
• By type, the oligonucleotide DNA microarrays segment had a major market revenue share of 45% in 2022.
• By type, the complementary DNA microarrays segment is anticipated to grow a noteworthy CAGR of 10.1% during the projected period.
• By application, the gene expression analysis segment contributed more than 46% of revenue share in 2022.
• By end-user, the academic & research institutes segment has held the major market share of 37% in 2022.
• By end-user, the diagnostic centers segment is predicted to grow at the fastest CAGR over the projected period.

Growth Factors

The DNA Microarray market experiences robust growth due to the escalating demand for personalized medicine and the increasing prevalence of genetic disorders. Technological advancements in microarray technologies, such as enhanced sensitivity and accuracy, are driving market expansion. Additionally, the growing focus on precision medicine and the surge in research activities in fields like oncology and pharmacogenomics contribute significantly to the market’s upward trajectory.

Regions Snapshot

The market exhibits a global presence, with North America, Europe, Asia-Pacific, and the rest of the world being key regions. North America, particularly the United States, dominates the market owing to well-established healthcare infrastructure, substantial investments in research and development, and a high prevalence of genetic disorders. Asia-Pacific is emerging as a lucrative market, propelled by increasing awareness, rising healthcare expenditure, and a growing emphasis on genomics research.

Get a Sample: https://www.precedenceresearch.com/sample/3648

DNA Microarray Market Scope

Read Also: Web 3.0 Market Size To Rake USD 65.78 Bn By 2032

DNA Microarray Market Dynamics

Drivers:

Key drivers of the DNA Microarray market include the continuous advancements in genomic research, rising government initiatives to promote genomics and personalized medicine, and the expanding application scope in various therapeutic areas. Additionally, the increasing adoption of DNA microarray technologies in clinical diagnostics and drug discovery processes fuels market growth.

Opportunities:

Opportunities in the DNA Microarray market lie in untapped emerging markets, collaborative efforts between industry players and research institutions, and the development of cost-effective and user-friendly microarray technologies. The integration of artificial intelligence and machine learning in data analysis presents a promising avenue for market players to explore and enhance the efficiency of microarray-based studies.

Challenges:

Despite the positive outlook, the DNA Microarray market faces challenges related to data standardization, ethical concerns surrounding genetic information, and the high cost of advanced microarray technologies. Additionally, the complexity of data interpretation and the need for skilled professionals pose challenges to widespread adoption.

Reasons to Purchase this Report:

• Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
• In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
• Market size in USD million and volume in million units provided for each segment and sub-segment.
• Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
• Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Recent Developments

• In 2020, Thermo Fisher Scientific Inc. partnered with QIAGEN N.V. to expand its offering of molecular diagnostics solutions, including DNA microarrays.
• In 2018, Agilent announced a strategic scientific collaboration with the University of Southern California (USC) to support innovative biomedical science and engineering research initiatives, fostering transformational advancements in these fields.
• In 2017, Bio-Rad Laboratories, Inc. acquired RainDance Technologies, Inc., a company specializing in droplet-based microfluidics solutions for genomics research, complementing its microarray offerings.

DNA Microarray Market Companies

• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Illumina, Inc.
• PerkinElmer, Inc.
• Bio-Rad Laboratories, Inc.
• Roche Diagnostics
• Qiagen N.V.
• Oxford Gene Technology (OGT)
• Applied Microarrays, Inc.
• Eurofins Genomics LLC
• LC Sciences
• Microarrays Inc.
• Arrayit Corporation
• BioCat GmbH
• Savyon Diagnostics Ltd.

Segments Covered in the Report

By Type

• Complementary DNA Microarrays
• Oligonucleotide DNA Microarrays
• Others

By Application

• Gene Expression Analysis
• Genotyping
• Others

By End-user

• Pharmaceutical and Biotechnology Companies
• Diagnostic Centers
• Hospitals and Clinics
• Academic and Research Institute
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on DNA Microarray Market 

5.1. COVID-19 Landscape: DNA Microarray Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global DNA Microarray Market, By Type

8.1. DNA Microarray Market, by Type, 2023-2032

8.1.1 Complementary DNA Microarrays

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Oligonucleotide DNA Microarrays

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global DNA Microarray Market, By Application

9.1. DNA Microarray Market, by Application, 2023-2032

9.1.1. Gene Expression Analysis

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Genotyping

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global DNA Microarray Market, By End-user 

10.1. DNA Microarray Market, by End-user, 2023-2032

10.1.1. Pharmaceutical and Biotechnology Companies

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Diagnostic Centers

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Hospitals and Clinics

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Academic and Research Institute

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global DNA Microarray Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2020-2032)

11.1.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.3. Market Revenue and Forecast, by End-user (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End-user (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End-user (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End-user (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End-user (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.3. Market Revenue and Forecast, by End-user (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End-user (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End-user (2020-2032)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Agilent Technologies, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Illumina, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. PerkinElmer, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bio-Rad Laboratories, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Roche Diagnostics

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Qiagen N.V.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Oxford Gene Technology (OGT)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Applied Microarrays, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Eurofins Genomics LLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/